InvestorsHub Logo
Followers 17
Posts 6023
Boards Moderated 0
Alias Born 12/09/2004

Re: DesertEagle post# 47792

Thursday, 02/14/2019 11:27:44 AM

Thursday, February 14, 2019 11:27:44 AM

Post# of 50157
I don't compare closely to the phase 3 timeline from long ago. I believe the slow enrollment under Simpson is more a reflection on lack of excitement in the medical community, so despite Simpson's honest efforts this may be a good rider on a mediocre horse. That is the opposite of what so many think, but there you have it.

Of course a certain percentage will not come close to 6 treatments, but the company is masking safety issues in Europe is a possibility. I am very confident this procedure is fairly safe, after all one patient opted for 8 treatments. Lack of spectacular success on any front so far allows me to think the product may not have what it takes, Medac news, more revenue growth, enrollment complete anywhere from May to September, anything to brighten the picture would be welcome
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News